Protein Turnover in the Osteoarthritic Knee

Status Completed

Clinical Trial Summary

Rationale: Osteoarthritis (OA) of the knee is a common cause of pain and disability, especially in people over the age of 65. In the current health care system both conservative (e.g. intra-articular injections with corticosteroids) and surgical (total knee replacement, TKR) treatment are applied. Although frequently used, certain effects of these treatments on protein metabolism remain unclear. It is well known that maintenance of different tissues is determined by a dynamic balance between protein synthesis and breakdown rates, with temporary changes in either protein synthesis or breakdown allowing net protein accretion or loss. Though protein supplementation has shown to be an effective nutritional strategy in stimulating muscle protein synthesis, it remains unclear to what extent other musculoskeletal tissues are able to respond to dietary protein supplementation. Therefore, the current study assesses the impact of preoperative protein supplementation on protein synthesis in different musculoskeletal tissues of the knee. Objective: To investigate the effect of preoperative protein supplementation on Hoffa's fat pad, synovium, tendon, bone, muscle, ligament, menisci, and cartilage protein synthesis of the OA knee. Study design: Randomized, parallel (two groups) study design. The intervention group will be compared to the control group. Study population: 24 adults with OA of the knee undergoing TKR. Intervention: Daily 40 g of pre-sleep protein two weeks before TKR or no intervention. Main study parameters/endpoints: Primary study parameters include protein synthesis rates and enrichments of Hoffa's fat pad, synovium, tendon, bone, muscle, ligament, menisci, and cartilage. Secondary parameters include whole-body protein synthesis, breakdown, oxidation, and net balance. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The risks involved in participating in this study are minimal. There are no potential effects known for the ingestion of protein. Muscle biopsies and tissue collection will be performed during the surgical procedure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03037294
Study type	Interventional
Source	Maastricht University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2017
Completion date	January 19, 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04040985` - Legion Primary Safety and Efficacy	N/A
Active, not recruiting	`NCT04525950` - Robotized Navigation Compared to Conventional Technique in Total Knee Replacement	N/A
Recruiting	`NCT04320914` - High Intensity Laser Therapy (Classes IV) and Ibuprofen Gel Phonophoresis for Treating Knee Osteoarthritis	N/A
Completed	`NCT03886142` - Platelet Rich Plasma Versus Radio Frequency for Chronic Knee Arthritis	N/A
Terminated	`NCT04072055` - MOTO Post-marketing Surveillance Study
Not yet recruiting	`NCT05290818` - Total Versus Robotic Assisted Unicompartmental Knee Replacement	N/A
Withdrawn	`NCT03271229` - Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee	Phase 2
Recruiting	`NCT05992038` - Use of a Putty as Gap Filler in Open-wedge Osteotomy	N/A
Recruiting	`NCT05505552` - Effects of Vitamin K on Lower-extremity Function in Adults With Osteoarthritis:	N/A
Recruiting	`NCT06066684` - Pain Phenotyping in Knee OA: a Pilot Trial
Completed	`NCT03847324` - Physiotherapy and Therapeutic Education on Patients With Pain Catastrophism Scheduled for a Total Knee Arthroplasty	N/A
Recruiting	`NCT05126485` - Biofeedback Retention in Individuals With AKA	Early Phase 1
Completed	`NCT04956393` - The SOAR (Stop OsteoARthritis) Program Proof-of-Concept Study	N/A
Recruiting	`NCT04541342` - Arthroscopic Evaluation of Cartilage Regeneration After Opening-wedge High Tibial Osteotomy	N/A
Completed	`NCT04391842` - Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis	Phase 1
Completed	`NCT03680807` - Power Production in Older Adults With Knee Osteoarthritis
Completed	`NCT03783455` - Effectiveness of Five Intraarticular Strategies on Knee Osteoarthritis	N/A
Recruiting	`NCT06264362` - Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia	N/A
Completed	`NCT05089253` - Effect of Physical Therapy Modalities in Osteoarthritis	N/A
Completed	`NCT04536519` - Foot Wear Modification Along With Physical Therapy in Knee Osteoarthritis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Protein Turnover in the Osteoarthritic Knee — KneeT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms